Social sciences research in neglected tropical diseases 3: Investment in social science research in neglected diseases of poverty: a case study of Bill and Melinda Gates Foundation

BackgroundThe level of funding provides a good proxy for the level of commitment or prioritisation given to a particular issue. While the need for research relevant to social, economic, cultural and behavioural aspects of neglected tropical diseases (NTD) control has been acknowledged, there is limited data on the level of funding that supports NTD social science research.MethodA case study was carried out in which the spending of a major independent funder, the Bill and Melinda Gates Foundation (BMGF) - was analysed. A total of 67 projects funded between October 1998 and November 2008 were identified from the BMGF database. With the help of keywords within the titles of 67 grantees, they were categorised as social science or non-social science research based on available definition of social science. A descriptive analysis was conducted.ResultsOf 67 projects analysed, 26 projects (39%) were social science related while 41 projects (61%) were basic science or other translational research including drug development. A total of US$ 697 million was spent to fund the projects, of which 35% ((US$ 241 million) went to social science research. Although the level of funding for social science research has generally been lower than that for non-social science research over 10 year period, social science research attracted more funding in 2004 and 2008.ConclusionThe evidence presented in this case study indicates that funding on NTD social science research compared to basic and translational research is not as low as it is perceived to be. However, as there is the acute need for improved delivery and utilisation of current NTD drugs/technologies, informed by research from social science approaches, funding priorities need to reflect the need to invest significantly more in NTD social science research.

[1]  G. Anderson,et al.  Spurring new research for neglected diseases. , 2009, Health affairs.

[2]  P. Allotey,et al.  Social Research on Neglected Diseases of Poverty: Continuing and Emerging Themes , 2009, PLoS neglected tropical diseases.

[3]  D. Malvy,et al.  Neglected Diseases in the News: A Content Analysis of Recent International Media Coverage Focussing on Leishmaniasis and Trypanosomiasis , 2008, PLoS neglected tropical diseases.

[4]  S. Heald,et al.  Applied Social Sciences for Public Health (ASSPH): higher degree training for implementation research on tropical diseases , 2007 .

[5]  Steven H. Woolf,et al.  The Break-Even Point: When Medical Advances Are Less Important Than Improving the Fidelity With Which They Are Delivered , 2005, The Annals of Family Medicine.

[6]  Rosalind Raine,et al.  Making Health Policy , 2005 .

[7]  A. Prüss-Ustün,et al.  The Global Burden of Disease Assessments—WHO Is Responsible? , 2007, PLoS neglected tropical diseases.

[8]  P. Allotey,et al.  Social sciences research in neglected tropical diseases 2: A bibliographic analysis , 2011, Health Research Policy and Systems.

[9]  Edward Nason,et al.  Health research: measuring the social, health and economic benefits , 2009, Canadian Medical Association Journal.

[10]  J. Guzman,et al.  Neglected Disease Research and Development: How Much Are We Really Spending? , 2009, PLoS medicine.

[11]  J. Leroy,et al.  Current priorities in health research funding and lack of impact on the number of child deaths per year. , 2007, American journal of public health.

[12]  D. Durrheim,et al.  Current Concepts Control of Neglected Tropical Diseases , 2007 .

[13]  P. Allotey,et al.  Social sciences research in neglected tropical diseases 1: the ongoing neglect in the neglected tropical diseases , 2010, Health research policy and systems.

[14]  T. Allen,et al.  Does mass drug administration for the integrated treatment of neglected tropical diseases really work? Assessing evidence for the control of schistosomiasis and soil-transmitted helminths in Uganda , 2011, Health research policy and systems.

[15]  Mary Moran,et al.  A Breakthrough in R&D for Neglected Diseases: New Ways to Get the Drugs We Need , 2005, PLoS Medicine.

[16]  J. Stockman,et al.  The Bill & Melinda Gates Foundation's grant-making programme for global health , 2011 .